Skip to contentClarengateINTELLIGENCE
Coverage & freshness About Clarengate
Companies/14041502

Eliptica Limited

Research and experimental development on biotechnology · Newbury

ActiveUnited KingdomIncorporated 2022Private Limited Company
Register Ask analyst

Ownership evidence

Reported ownership and control rights in this business, with source dates.

Reported ownership & control

1 without an end date · 3 ceased
Bruker Switzerland AgCorporate
Shares: over 25%, up to 50%Voting rights: over 25%, up to 50%

Notified 2023-12-20 · No cessation recorded

Source record 175642676
Show 3 ceased records
CB
Mr Charles BrigdenIndividual
Shares: over 25%, up to 50%Voting rights: over 25%, up to 50%

Notified 2022-04-12 · Ceased 2022-09-08

Source record 174890967
MR
Dr Markus RalserIndividual
Shares: over 25%, up to 50%Voting rights: over 25%, up to 50%

Notified 2022-04-12 · Ceased 2022-09-08

Source record 174890970
AZ
Aleksej ZelezniakIndividual
Shares: over 25%, up to 50%Voting rights: over 25%, up to 50%

Notified 2022-04-12 · Ceased 2022-09-08

Source record 174891742

People behind the business

Current appointments and the wider business interests of each person.

Appointments

3 current · 0 historical
MR
Markus RalserCurrent director
Appointed 2022-09-08 · 4 yrs · Cso
GK
Gary KruppaCurrent director
Appointed 2022-09-08 · 4 yrs · Director
CB
Charles BrigdenCurrent director
Appointed 2022-04-12 · 4 yrs · Business Executive
+1 other

Board profile

People with appointments
3
Directors assessed
3
Median age
57
Under 35
0
65 and over
1
Disqualified match
None active